Eleven peptides released from faba bean protein during simulated digestion were tested, with seven showing potent antioxidant activity and four showing ACE inhibitory activity through a noncompetitive mechanism.
IC50 = 43 μMThe most potent faba bean peptide (TETWNPNHPEL) inhibited ACE — the same enzyme targeted by blood pressure drugs — at a micromolar concentration through noncompetitive binding
What the researchers found
Of 11 synthesized faba bean-derived peptides:
Antioxidant activity (7 peptides):
- TETWNPNHPEL showed the highest activity: ABTS EC50 = 0.5 ± 0.2 mM; DPPH EC50 = 2.1 ± 0.1 mM
- Other active peptides: NYDEGSEPR, TETWNPNHPE, VIPTEPPH, VIPTEPPHA, VVIPTEPPHA, VVIPTEPPH
ACE inhibitory activity (4 peptides):
- TETWNPNHPEL: IC50 = 43 ± 1 μM (most potent)
- VVIPTEPPHA: IC50 = 50 ± 5 μM
- TETWNPNHPE: IC50 = 90 ± 10 μM
- VIPTEPPHA: IC50 = 123 ± 5 μM
Kinetic studies and molecular docking confirmed all ACE-inhibitory peptides act through a noncompetitive mechanism — they bind to a site other than the enzyme's active site.
Why it matters
High blood pressure affects over a billion people worldwide, and ACE inhibitor drugs are among the most prescribed medications. Finding natural food-derived peptides with ACE-inhibitory activity could lead to functional foods or supplements that help manage blood pressure with fewer side effects than synthetic drugs. The dual activity — both antioxidant and ACE-inhibitory — in the same peptides makes them particularly interesting for cardiovascular health, since oxidative stress and hypertension are closely linked.
How the study worked
Faba bean flour was subjected to in vitro gastrointestinal digestion (simulating stomach and intestinal conditions). Eleven peptides identified from the digest were chemically synthesized for individual testing. Antioxidant activity was measured using ABTS and DPPH radical scavenging assays. ACE inhibitory activity was quantified by IC50 values. Enzyme kinetic studies determined the inhibition mechanism (competitive vs. noncompetitive). Molecular docking simulations modeled how the peptides interact with the ACE enzyme.
What this study cannot tell us
All testing was performed in vitro — digestion was simulated, not actual human digestion, and ACE inhibition was measured in a test tube, not in human blood vessels. The IC50 values (43-123 μM) need to be evaluated in the context of achievable plasma concentrations after oral consumption, which is typically much lower. Many food-derived ACE-inhibitory peptides lose activity after absorption or further metabolism. No animal or human blood pressure studies were conducted. The peptide sequences were identified from a simulated digest and may not represent the exact peptides released during actual human digestion.
How to read the evidence
This is an in vitro biochemical study with no animal or human data. The peptide characterization is rigorous (synthesized peptides, kinetic studies, molecular docking), but the clinical relevance of the observed activities is unproven. Evidence is at the basic research level.
When this study was published
Published in 2024, this study contributes to the active field of food-derived bioactive peptides. Interest in plant protein-derived health-promoting peptides continues to grow alongside the plant-based food movement.
The bigger picture
Food-derived bioactive peptides are a rapidly growing area of nutritional science. ACE-inhibitory peptides from milk (lactotripeptides IPP and VPP) are already marketed as functional food ingredients in some countries. This study extends the concept to plant-based proteins, which is significant as plant-based diets become more popular. Faba beans are also a sustainable crop with high protein content, making them an attractive source for nutraceutical development.
Questions still open
- Can these faba bean peptides survive absorption through the intestinal wall intact and reach the bloodstream at concentrations sufficient for ACE inhibition?
- Would regular faba bean consumption produce measurable blood pressure reduction in hypertensive individuals?
- How do these peptides compare in potency and bioavailability to dairy-derived ACE-inhibitory peptides that are already commercialized?
Common questions
Could eating faba beans lower blood pressure?
What is ACE and why does inhibiting it lower blood pressure?
Read the original research
Antioxidant and Angiotensin-Converting Enzyme Inhibitory Activity of Faba Bean-Derived Peptides After In Vitro Gastrointestinal Digestion: Insight into Their Mechanism of Action.
Journal of agricultural and food chemistry, 72(12), 6432-6443
Citation
Martineau-Côté, Delphine; Achouri, Allaoua; Karboune, Salwa; L'Hocine, Lamia. (2024). Antioxidant and Angiotensin-Converting Enzyme Inhibitory Activity of Faba Bean-Derived Peptides After In Vitro Gastrointestinal Digestion: Insight into Their Mechanism of Action.. Journal of agricultural and food chemistry, 72(12), 6432-6443. https://doi.org/10.1021/acs.jafc.4c00829